Association between Human Leukocyte Antigen and End-Stage Renal Disease in Patients from Transylvania, Romania
- PMID: 37686189
- PMCID: PMC10488296
- DOI: 10.3390/ijms241713383
Association between Human Leukocyte Antigen and End-Stage Renal Disease in Patients from Transylvania, Romania
Abstract
End-stage renal disease (ESRD) is the final stage of chronic kidney disease. This study explored the association between human leukocyte antigen (HLA) and ESRD. The interaction between genetic and environmental factors may also play a role in the development of ESRD. The study included 2392 ESRD patients who were awaiting renal transplantation. Blood samples were genotyped by SSOP and SSP-PCR methods. Multivariate logistic regression analysis showed that HLA-A*11 (p = 0.027), HLA-A*34 (p = 0.017), HLA-A*69 (p = 0.012), HLA-B*41 (p < 0.001), HLA-B*50 (p = 0.004), HLA-DRB1*10 (p = 0.027), and HLA-DRB1*14 (p = 0.004) were positively associated with ESRD (OR > 1); HLA-DRB1*07 (p < 0.001), HLA-DRB1*08 (p = 0.005), and HLA-DRB1*13 (p < 0.001) were protective against ESRD (OR < 1); and the three-locus haplotype HLA-A*02-B*41-DRB1*03, containing one susceptible allele, was strongly associated with ESRD (p < 0.001, OR = 3.15). In conclusion, this retrospective analysis of HLA typing in patients with ESRD of various etiologies suggests that molecular data on the HLA polymorphism should be collected in order to identify high-risk ESRD patients and to improve graft survival after kidney transplantation.
Keywords: allele frequency; end-stage renal disease; haplotype frequency; human leukocyte antigen.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Association between the polymorphism of HLA and ESRD in Dalian Han population located in north of China.Immunol Invest. 2018 Feb;47(2):212-219. doi: 10.1080/08820139.2017.1416397. Epub 2017 Dec 19. Immunol Invest. 2018. PMID: 29257902
-
A single center study of protective and susceptible HLA alleles and haplotypes with end-stage renal disease in China.Hum Immunol. 2019 Nov;80(11):943-947. doi: 10.1016/j.humimm.2019.09.001. Epub 2019 Sep 11. Hum Immunol. 2019. PMID: 31521393
-
HLA polymorphism and susceptibility to end-stage renal disease in Cantonese patients awaiting kidney transplantation.PLoS One. 2014 Mar 6;9(6):e90869. doi: 10.1371/journal.pone.0090869. eCollection 2014. PLoS One. 2014. PMID: 24603486 Free PMC article.
-
Revisiting the association between human leukocyte antigen and end-stage renal disease.PLoS One. 2020 Sep 11;15(9):e0238878. doi: 10.1371/journal.pone.0238878. eCollection 2020. PLoS One. 2020. PMID: 32915858 Free PMC article.
-
HLA-A, -B, and -DRB1 allele and haplotype diversity in a cohort of Brazilian renal transplant candidates.Hum Immunol. 2016 Jun;77(6):464-9. doi: 10.1016/j.humimm.2016.04.017. Epub 2016 Apr 22. Hum Immunol. 2016. PMID: 27108963 Review.
Cited by
-
Associations between end stage renal disease and HLA polymorphisms in the Guangxi Zhuang population.Sci Rep. 2024 Sep 18;14(1):21765. doi: 10.1038/s41598-024-72688-2. Sci Rep. 2024. PMID: 39294236 Free PMC article.
-
Orchestrating the Impact of KIR/HLA Interactions on Kidney Transplant.Int J Mol Sci. 2024 Jul 28;25(15):8228. doi: 10.3390/ijms25158228. Int J Mol Sci. 2024. PMID: 39125798 Free PMC article.
References
-
- Pop C., Gheorghe Fronea O.F., Branea I.A., Itu L.M., Darabont R., Parepa I., Benedek T., Dorobantu M. Prevalence and Predictors of Renal Disease in a National Representative Sample of the Romanian Adult Population: Data from the SEPHAR IV Survey. Diagnostics. 2022;12:3199. doi: 10.3390/diagnostics12123199. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials